The store will not work correctly when cookies are disabled.
5-Fluoro-3-((E)-2-pyridin-3-yl-vinyl)-1H-indole
ID: ALA168956
PubChem CID: 44381485
Max Phase: Preclinical
Molecular Formula: C15H11FN2
Molecular Weight: 238.26
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Fc1ccc2[nH]cc(/C=C/c3cccnc3)c2c1
Standard InChI: InChI=1S/C15H11FN2/c16-13-5-6-15-14(8-13)12(10-18-15)4-3-11-2-1-7-17-9-11/h1-10,18H/b4-3+
Standard InChI Key: WPABSLYILGSEFI-ONEGZZNKSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
1.6292 -1.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6292 -2.3500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8417 -1.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1167 -1.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8792 -0.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8417 -2.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6917 -0.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1250 -0.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0125 1.6958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1250 -2.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5875 -1.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9417 0.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5875 -2.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3083 -0.8500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.7542 0.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4542 2.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 1.3458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6500 2.1333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 4 1 0
3 1 1 0
4 1 2 0
5 1 1 0
6 3 1 0
7 5 2 0
8 3 2 0
9 15 1 0
10 6 2 0
11 8 1 0
12 7 1 0
13 11 2 0
14 11 1 0
15 12 2 0
16 18 1 0
17 12 1 0
18 17 2 0
6 2 1 0
13 10 1 0
9 16 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 238.26 | Molecular Weight (Monoisotopic): 238.0906 | AlogP: 3.87 | #Rotatable Bonds: 2 |
Polar Surface Area: 28.68 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.88 | CX LogP: 3.34 | CX LogD: 3.34 |
Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.72 | Np Likeness Score: -0.90 |
References
1. Madge D, Hazelwood R, Iyer R, Jones H, Salter M. (1996) Novel tryptophan dioxygenase inhibitors and combined tryptophan dioxygenase/5-HT reuptake inhibitors, 6 (7): [10.1016/0960-894X(96)00124-2] |
2. Dolusić E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R.. (2011) Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators., 54 (15): [PMID:21726069] [10.1021/jm2006782] |